drugset / Trial / NCT02336854
Tacrobell tab_Phase1_PK
RandomizedCrossoverOpen-labelTreatment
Summary
A randomized, open-label, two-way crossover study to assess the tolerability and pharmacokinetics of Tacrobell® Tab. and Prograf® Cap. after a single oral dose in healthy male volunteers.
Timeline
- Start
- 2015-01-12
- Primary completion
- 2015-02-02
- Completion
- 2015-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tacrolimus | Small molecule | 2 mg | Oral |